Ventral Hernia Mesh Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mesh Type, By Indication, By Procedure, By End Use, By Region and Competition, 2020-2030F

Description

The Global Ventral Hernia Mesh Devices Market was valued at USD 841.06 Million in 2024 and is projected to reach USD 1375.61 Million by 2030, growing at a CAGR of 8.52% during the forecast period. The market is driven by a growing prevalence of ventral hernias, often linked to obesity, prior abdominal surgeries, and aging populations. These mesh devices play a crucial role in surgical repairs by reinforcing weakened abdominal walls and reducing the risk of recurrence.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 841.06 Million
Market Size 2030	USD 1375.61 Million
CAGR 2025-2030	8.52%
Fastest Growing Segment	Robotic Surgery
Largest Market	North America

As the demand for minimally invasive procedures increases, mesh-based repairs are increasingly preferred over traditional suture methods due to improved patient outcomes and lower complication rates. Healthcare systems are placing greater emphasis on faster recovery and long-term durability, which is contributing to the widespread adoption of advanced mesh products. Innovations in mesh design-such as lightweight, absorbable, and composite materials-are enhancing biocompatibility, surgical efficiency, and patient comfort. With rising awareness among patients and increasing investments in research and development, the global ventral hernia mesh devices market is poised for sustained growth.

Key Market Drivers

Rising Prevalence of Ventral Hernias and Related Risk Factors

The increasing incidence of ventral hernias globally is a primary driver of market growth. In the United States alone, over 350,000 ventral hernia repair procedures are performed annually, underscoring the growing clinical need for effective treatment solutions. Prevalence is notably higher among individuals aged 45 and above, driven by factors such as tissue degeneration and obesity.

With approximately 600,000 repairs performed annually, as reported by the CDC, the demand for durable and reliable mesh devices is intensifying. Obesity-affecting over 40% of U.S. adults-contributes to elevated intra-abdominal pressure, further heightening the risk of hernia development. These statistics reflect a growing and persistent demand for mesh-based repair products that can provide long-term reinforcement and reduce recurrence rates.

Key Market Challenges

High Cost of Advanced Mesh Devices Limiting Accessibility

The high cost associated with advanced ventral hernia mesh products remains a key barrier to wider adoption, especially in low- and middle-income countries. These premium devices-often featuring bioresorbable materials or advanced composites-command elevated prices due to the use of proprietary technologies, strict regulatory requirements, and high production costs.

Hospitals operating under budget constraints and patients lacking robust insurance coverage may struggle to access these advanced solutions. In resource-limited settings, the preference often shifts toward less expensive or traditional repair methods, despite higher risks of complications. Even in developed markets, limited reimbursement for next-generation meshes can discourage surgeons from adopting the latest products, further slowing innovation diffusion and creating disparities in patient outcomes.

Key Market Trends

Rising Demand for Lightweight and Composite Mesh Materials

A notable trend in the ventral hernia mesh market is the shift toward lightweight and composite mesh materials that offer enhanced patient comfort and reduced post-operative complications. Conventional heavyweight meshes have been associated with adverse outcomes such as chronic pain and foreign body sensation.

Modern lightweight meshes, featuring larger pores and reduced material density, allow for better integration with host tissue and lower inflammatory responses. These design improvements contribute to more favorable healing, decreased fibrosis, and enhanced overall patient satisfaction. As surgeons seek safer, more effective solutions with fewer long-term risks, the demand for these advanced mesh materials continues to grow across both inpatient and outpatient settings.

Key Market Players

Medtronic plc
Becton, Dickinson and Company (BD)
Meril Life Sciences Pvt. Ltd.
Novus Scientific AB
B. Braun SE
TELA Bio, Inc.
BG Medical LLC
Integra LifeSciences Corporation
W. L. Gore & Associates, Inc.
Atrium Medical

Report Scope:

In this report, the Global Ventral Hernia Mesh Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ventral Hernia Mesh Devices Market, By Mesh Type:

Resorbable Mesh
Partially Absorbable Mesh
Non-Resorbable Mesh

Ventral Hernia Mesh Devices Market, By Indication:

Umbilical Hernia
Epigastric Hernia
Incisional Hernia
Others

Ventral Hernia Mesh Devices Market, By Procedure:

Open Surgery
Laparoscopic Surgery
Robotic Surgery
Others

Ventral Hernia Mesh Devices Market, By End Use:

Inpatient Facilities
Outpatient Facilities

Ventral Hernia Mesh Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ventral Hernia Mesh Devices Market.

Available Customizations:

Global Ventral Hernia Mesh Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Ventral Hernia Mesh Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Mesh Type (Resorbable Mesh, Partially Absorbable Mesh, Non-Resorbable Mesh)
- 5.2.2. By Indication (Umbilical Hernia, Epigastric Hernia, Incisional Hernia, Others)
- 5.2.3. By Procedure (Open Surgery, Laparoscopic Surgery, Robotic Surgery, Others)
- 5.2.4. By End Use (Inpatient Facilities, Outpatient Facilities)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
5.3. Market Map

6. North America Ventral Hernia Mesh Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Mesh Type
- 6.2.2. By Indication
- 6.2.3. By Procedure
- 6.2.4. By End Use
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Ventral Hernia Mesh Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Mesh Type
    - 6.3.1.2.2. By Indication
    - 6.3.1.2.3. By Procedure
    - 6.3.1.2.4. By End Use
- 6.3.2. Mexico Ventral Hernia Mesh Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Mesh Type
    - 6.3.2.2.2. By Indication
    - 6.3.2.2.3. By Procedure
    - 6.3.2.2.4. By End Use
- 6.3.3. Canada Ventral Hernia Mesh Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Mesh Type
    - 6.3.3.2.2. By Indication
    - 6.3.3.2.3. By Procedure
    - 6.3.3.2.4. By End Use

7. Europe Ventral Hernia Mesh Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Mesh Type
- 7.2.2. By Indication
- 7.2.3. By Procedure
- 7.2.4. By End Use
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Ventral Hernia Mesh Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Mesh Type
    - 7.3.1.2.2. By Indication
    - 7.3.1.2.3. By Procedure
    - 7.3.1.2.4. By End Use
- 7.3.2. Germany Ventral Hernia Mesh Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Mesh Type
    - 7.3.2.2.2. By Indication
    - 7.3.2.2.3. By Procedure
    - 7.3.2.2.4. By End Use
- 7.3.3. United Kingdom Ventral Hernia Mesh Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Mesh Type
    - 7.3.3.2.2. By Indication
    - 7.3.3.2.3. By Procedure
    - 7.3.3.2.4. By End Use
- 7.3.4. Italy Ventral Hernia Mesh Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Mesh Type
    - 7.3.4.2.2. By Indication
    - 7.3.4.2.3. By Procedure
    - 7.3.4.2.4. By End Use
- 7.3.5. Spain Ventral Hernia Mesh Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Mesh Type
    - 7.3.5.2.2. By Indication
    - 7.3.5.2.3. By Procedure
    - 7.3.5.2.4. By End Use

8. Asia-Pacific Ventral Hernia Mesh Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Mesh Type
- 8.2.2. By Indication
- 8.2.3. By Procedure
- 8.2.4. By End Use
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Ventral Hernia Mesh Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Mesh Type
    - 8.3.1.2.2. By Indication
    - 8.3.1.2.3. By Procedure
    - 8.3.1.2.4. By End Use
- 8.3.2. India Ventral Hernia Mesh Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Mesh Type
    - 8.3.2.2.2. By Indication
    - 8.3.2.2.3. By Procedure
    - 8.3.2.2.4. By End Use
- 8.3.3. South Korea Ventral Hernia Mesh Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Mesh Type
    - 8.3.3.2.2. By Indication
    - 8.3.3.2.3. By Procedure
    - 8.3.3.2.4. By End Use
- 8.3.4. Japan Ventral Hernia Mesh Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Mesh Type
    - 8.3.4.2.2. By Indication
    - 8.3.4.2.3. By Procedure
    - 8.3.4.2.4. By End Use
- 8.3.5. Australia Ventral Hernia Mesh Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Mesh Type
    - 8.3.5.2.2. By Indication
    - 8.3.5.2.3. By Procedure
    - 8.3.5.2.4. By End Use

9. South America Ventral Hernia Mesh Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Mesh Type
- 9.2.2. By Indication
- 9.2.3. By Procedure
- 9.2.4. By End Use
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Ventral Hernia Mesh Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Mesh Type
    - 9.3.1.2.2. By Indication
    - 9.3.1.2.3. By Procedure
    - 9.3.1.2.4. By End Use
- 9.3.2. Argentina Ventral Hernia Mesh Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Mesh Type
    - 9.3.2.2.2. By Indication
    - 9.3.2.2.3. By Procedure
    - 9.3.2.2.4. By End Use
- 9.3.3. Colombia Ventral Hernia Mesh Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Mesh Type
    - 9.3.3.2.2. By Indication
    - 9.3.3.2.3. By Procedure
    - 9.3.3.2.4. By End Use

10. Middle East and Africa Ventral Hernia Mesh Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Mesh Type
- 10.2.2. By Indication
- 10.2.3. By Procedure
- 10.2.4. By End Use
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Ventral Hernia Mesh Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Mesh Type
    - 10.3.1.2.2. By Indication
    - 10.3.1.2.3. By Procedure
    - 10.3.1.2.4. By End Use
- 10.3.2. Saudi Arabia Ventral Hernia Mesh Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Mesh Type
    - 10.3.2.2.2. By Indication
    - 10.3.2.2.3. By Procedure
    - 10.3.2.2.4. By End Use
- 10.3.3. UAE Ventral Hernia Mesh Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Mesh Type
    - 10.3.3.2.2. By Indication
    - 10.3.3.2.3. By Procedure
    - 10.3.3.2.4. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Medtronic plc
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Becton, Dickinson and Company (BD)
15.3. Meril Life Sciences Pvt. Ltd.
15.4. Novus Scientific AB
15.5. B. Braun SE
15.6. TELA Bio, Inc.
15.7. BG Medical LLC
15.8. Integra LifeSciences Corporation
15.9. W. L. Gore & Associates, Inc.
15.10. Atrium Medical